205 related articles for article (PubMed ID: 28782677)
21. [Comparison of PSAD and PSAD-TZ value in prostatic hyperplasia and prostatic cancer].
Fu Q; Yao DH; Jiang YQ
Zhonghua Nan Ke Xue; 2002 Dec; 8(6):411-3. PubMed ID: 12593013
[TBL] [Abstract][Full Text] [Related]
22. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
[TBL] [Abstract][Full Text] [Related]
24. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
25. Amide Proton Transfer Could Provide More Accurate Lesion Characterization in the Transition Zone of the Prostate.
Guo Z; Qin X; Mu R; Lv J; Meng Z; Zheng W; Zhuang Z; Zhu X
J Magn Reson Imaging; 2022 Nov; 56(5):1311-1319. PubMed ID: 35429190
[TBL] [Abstract][Full Text] [Related]
26. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
27. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
[TBL] [Abstract][Full Text] [Related]
28. T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlations.
Valentini AL; Gui B; Cina A; Pinto F; Totaro A; Pierconti F; Bassi PF; Bonomo L
Eur J Radiol; 2012 Nov; 81(11):3090-5. PubMed ID: 22727777
[TBL] [Abstract][Full Text] [Related]
29. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
30. Development of an ELISA for sPSP94 and utility of the sPSP94/sPSA ratio as a diagnostic indicator to differentiate between benign prostatic hyperplasia and prostate cancer.
Mhatre DR; Mahale SD; Khatkhatay MI; Desai SS; Jagtap DD; Dhabalia JV; Tongaonkar HB; Desai MP; Dandekar SP; Varadkar AM
Clin Chim Acta; 2014 Sep; 436():256-62. PubMed ID: 24952364
[TBL] [Abstract][Full Text] [Related]
31. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases.
Ren J; Huan Y; Wang H; Zhao H; Ge Y; Chang Y; Liu Y
Abdom Imaging; 2008; 33(6):724-8. PubMed ID: 18219519
[TBL] [Abstract][Full Text] [Related]
32. Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction.
Jambor I; Pesola M; Taimen P; Merisaari H; Boström PJ; Minn H; Liimatainen T; Aronen HJ
Magn Reson Med; 2016 Jan; 75(1):337-44. PubMed ID: 25733132
[TBL] [Abstract][Full Text] [Related]
33. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
Ren J; Huan Y; Wang H; Chang YJ; Zhao HT; Ge YL; Liu Y; Yang Y
Clin Radiol; 2008 Feb; 63(2):153-9. PubMed ID: 18194690
[TBL] [Abstract][Full Text] [Related]
34. Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI.
Song Y; Zhang YD; Yan X; Liu H; Zhou M; Hu B; Yang G
J Magn Reson Imaging; 2018 Dec; 48(6):1570-1577. PubMed ID: 29659067
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
J Magn Reson Imaging; 2009 Jun; 29(6):1360-6. PubMed ID: 19472393
[TBL] [Abstract][Full Text] [Related]
36. [Value of magnetic resonance imaging for early diagnosis of prostatic carcinoma in central zone].
He H; Fan S; Li Y; Ke M; Li Y; Chen B; Yu H
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1051-4. PubMed ID: 24851886
[TBL] [Abstract][Full Text] [Related]
37. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer: computer-aided diagnosis with multiparametric 3-T MR imaging--effect on observer performance.
Hambrock T; Vos PC; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ
Radiology; 2013 Feb; 266(2):521-30. PubMed ID: 23204542
[TBL] [Abstract][Full Text] [Related]
39. Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer.
Li J; Ren S; Piao HL; Wang F; Yin P; Xu C; Lu X; Ye G; Shao Y; Yan M; Zhao X; Sun Y; Xu G
Sci Rep; 2016 Feb; 6():20984. PubMed ID: 26865432
[TBL] [Abstract][Full Text] [Related]
40. Diffusion kurtosis imaging study of prostate cancer: preliminary findings.
Tamura C; Shinmoto H; Soga S; Okamura T; Sato H; Okuaki T; Pang Y; Kosuda S; Kaji T
J Magn Reson Imaging; 2014 Sep; 40(3):723-9. PubMed ID: 24924835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
